Optimizing Preclinical Oncology at Tumour Models Summit Nordics 2025
ChemPartner is headed to Tumour Models Summit Nordics 2025, a key gathering for experts in in vivo and in vitro tumour modelling. Our team will be available to discuss how our cutting-edge preclinical models enhance target selection, biomarker discovery, and clinical translatability. Whether you’re exploring novel tumour models or refining your translational strategy, let’s connect in Stockholm this April.